A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies
|
|||||
|
       
  |
Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine. . . . → Read More: Trial Requested for Covid-19 Vaccine Nasal Spray 
An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits 
Researchers began screening participants for a clinical trial assessing insulin formulated as capsules for people with type 2 diabetes. . . . → Read More: Trial Underway Testing Insulin Capsules 
A university lab is designing a system that allows for people with stroke to perform rehabilitation at home, while still guided remotely by a therapist. . . . → Read More: Therapist-Guided Home Stroke Rehab System in Works 
A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems. . . . → Read More: Lightweight AI Chip Designer Raises $2.8M in Seed Funds 
Researchers are enrolling patients in a clinical trial testing magnetic waves to induce small seizures as a treatment for depression from bipolar disorder. . . . → Read More: Trial Testing Magnetic Waves for Bipolar Depression 
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches 
A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway 
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
